FFAR1; FFAR4; GPBAR1; | |
PPARA; PPARD; PPARG; | |
NR1H4; | |
ALOX15; HPGD; AKR1B10; | |
FABP3; LMNA; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 5.250E-09 | 2.286E-05 | FFAR4, NR1H4, PPARA, PPARD, PPARG |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 1.782E-08 | 4.311E-05 | NR1H4, PPARA, PPARD, PPARG |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 3.815E-08 | 7.009E-05 | NR1H4, PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 6.408E-08 | 9.966E-05 | FABP3, PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 1.317E-07 | 1.593E-04 | FABP3, FFAR1, NR1H4, PPARG |
MF | Unclassified; | GO:0004872; receptor activity | 6.394E-07 | 4.491E-04 | FFAR1, FFAR4, GPBAR1, HPGD, NR1H4, PPARA, PPARD, PPARG |
BP | GO:0009987; cellular process | GO:0043401; steroid hormone mediated signaling pathway | 9.299E-07 | 5.956E-04 | NR1H4, PPARA, PPARD, PPARG |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 1.061E-06 | 6.418E-04 | GPBAR1, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 1.061E-06 | 6.418E-04 | GPBAR1, NR1H4 |
BP | GO:0008152; metabolic process | GO:0006367; transcription initiation from RNA polymerase II promoter | 2.131E-06 | 1.160E-03 | NR1H4, PPARA, PPARD, PPARG |
BP | GO:0009987; cellular process | GO:0030522; intracellular receptor signaling pathway | 3.045E-06 | 1.507E-03 | NR1H4, PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 3.534E-06 | 1.673E-03 | PPARA, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 5.300E-06 | 2.308E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 5.300E-06 | 2.308E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 5.300E-06 | 2.308E-03 | ALOX15, HPGD |
MF | GO:0005488; binding | GO:0050543; icosatetraenoic acid binding | 5.300E-06 | 2.308E-03 | FABP3, PPARG |
BP | GO:0023052; signaling | GO:0032024; positive regulation of insulin secretion | 8.974E-06 | 3.689E-03 | FFAR1, NR1H4, PPARD |
BP | GO:0008152; metabolic process | GO:0071073; positive regulation of phospholipid biosynthetic process | 1.271E-05 | 4.941E-03 | FABP3, NR1H4 |
BP | GO:0050896; response to stimulus | GO:0042060; wound healing | 1.306E-05 | 4.988E-03 | ALOX15, PPARA, PPARD |
MF | GO:0060089; molecular transducer activity | GO:0004955; prostaglandin receptor activity | 1.588E-05 | 5.961E-03 | HPGD, PPARG |
BP | GO:0008152; metabolic process | GO:1902894; negative regulation of pri-miRNA transcription from RNA polymerase II promoter | 1.940E-05 | 6.705E-03 | PPARA, PPARD |
BP | GO:0009987; cellular process | GO:0010745; negative regulation of macrophage derived foam cell differentiation | 2.749E-05 | 8.676E-03 | PPARA, PPARG |
BP | GO:0050896; response to stimulus | GO:0009725; response to hormone | 2.975E-05 | 9.255E-03 | FABP3, FFAR4, HPGD, PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0046321; positive regulation of fatty acid oxidation | 3.206E-05 | 9.697E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0032966; negative regulation of collagen biosynthetic process | 3.206E-05 | 9.697E-03 | PPARD, PPARG |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 6.289E-08 | 1.887E-06 | FABP3, PPARG, PPARA, PPARD |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 5.010E-03 | 7.516E-02 | HPGD, PPARG |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 2.274E-02 | 8.529E-02 | PPARG, PPARD |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 1.727E-02 | 8.529E-02 | PPARG |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.727E-02 | 8.529E-02 | ALOX15 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00040 | Pentose and glucuronate interconversions | 2.139E-02 | 8.529E-02 | AKR1B10 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 1.786E-02 | 8.529E-02 | AKR1B10 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00051 | Fructose and mannose metabolism | 1.904E-02 | 8.529E-02 | AKR1B10 |
09150 Organismal Systems | 09152 Endocrine system | hsa04911 | Insulin secretion | 4.984E-02 | 9.163E-02 | FFAR1 |
09160 Human Diseases | 09165 Cardiovascular diseases | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 4.352E-02 | 9.163E-02 | LMNA |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |